Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
1.340
+0.040 (3.08%)
At close: Nov 21, 2025, 4:00 PM EST
1.290
-0.050 (-3.73%)
After-hours: Nov 21, 2025, 4:09 PM EST
Zentalis Pharmaceuticals Market Cap
Zentalis Pharmaceuticals has a market cap or net worth of $96.82 million as of November 21, 2025. Its market cap has decreased by -64.54% in one year.
Market Cap
96.82M
Enterprise Value
-143.42M
1-Year Change
-64.54%
Ranking
Category
Stock Price
$1.34
Market Cap Chart
Since April 3, 2020, Zentalis Pharmaceuticals's market cap has decreased from $587.46M to $96.82M, a decrease of -83.52%. That is a compound annual growth rate of -27.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 21, 2025 | 96.82M | -55.16% |
| Dec 31, 2024 | 215.93M | -79.86% |
| Dec 29, 2023 | 1.07B | -6.72% |
| Dec 30, 2022 | 1.15B | -69.82% |
| Dec 31, 2021 | 3.81B | 80.54% |
| Dec 31, 2020 | 2.11B | 259.09% |
| Apr 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 951.15B |
| Johnson & Johnson | 495.57B |
| AbbVie | 419.15B |
| UnitedHealth Group | 290.02B |
| AstraZeneca | 280.49B |
| Merck & Co. | 244.69B |
| Novartis AG | 243.93B |
| Abbott Laboratories | 223.55B |